HOME   |    PDF   |   


Title

Evaluation of non-alcoholic fatty liver disease in metabolic syndrome patients using fibro scan

 

Authors

Alok Ranjan 1,*, Raj Kumar Prasad 2, Amit Vasant Deshpande 3, Ambadas Rathod 4 & Johanna Lisbeth Vásquez Herrera 5

 

Affiliation

1Department of Ophthalmology, Dr. Ram Manohar Lohia Institute of Medical Sciences (Dr. RMLIMS), Lucknow, Uttar Pradesh, India; 2Department of Physiology, Sanskarm School of Medical Sciences, Patauda, Jhajjar, Haryana, India; 3Department of Community Medicine, Datta Meghe Medical College, Datta Meghe Institute of Higher Education and Research, Wanadongri, Nagpur, Maharashtra, India; 4Department of General Medicine, Government Medical College and Hospital, Chandigarh, India; 5Department of Medicine, Technical University of Cotopaxi, Ecuador, South America; *Corresponding author

 

Email

Alok Ranjan - E-mail: dr.alok14@gmail.com
Raj Kumar Prasad - E-mail: rajgmc03@gmail.com
Amit Vasant Deshpande - E-mail: amitvd1977@gmail.com
Ambadas Rathod - E-mail: ambadasrathod100@gmail.com
Johanna Lisbeth Vásquez Herrera - E-mail: johalis1993@gmail.com
 

Article Type

Research Article

 

Date

Received October 1, 2026; Revised October 31, 2026; Accepted October 31, 2026, Published October 31, 2026

 

Abstract

Non-alcoholic fatty liver disease (NAFLD) is common in metabolic syndrome and may progress to advanced liver disease. Therefore, it is of interest to evaluate the hepatic steatosis and fibrosis using FibroScan in 100 adults with metabolic syndrome. Hepatic steatosis was common, while higher CAP and LSM values were associated with increased body mass index, fasting glucose, HbA1c, triglycerides and waist circumference (p < 0.05). Obesity and diabetes were identified as independent predictors of advanced fibrosis. Thus, fibroScan facilitates early detection and risk assessment of NAFLD in patients with metabolic syndrome.

 

Keywords

Non-alcoholic fatty liver disease (NAFLD), metabolic syndrome, fibroscan, transient elastography, controlled attenuation parameter, liver stiffness, hepatic steatosis, fibrosis

 

Citation

Ranjan et al. Bioinformation 22(10): 7527-7531 (2026)

 

Edited by

Ritik Kashwani

 

ISSN

0973-2063

 

Publisher

Biomedical Informatics

 

License

This is an Open Access article which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. This is distributed under the terms of the Creative Commons Attribution License.